Intensity Therapeutics
INTS4.2501.19% ( +0.050 )
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Intensity Therapeutics(INTS) predict that the Revenue is 0 (--%), Meet estimate;the EBIT is -2.526 M (+25.57%), Beat estimate;the EPS is -0.96 (+82.55%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.00B--
0.00B--
0.00B--%
EBITExceed expectations
-0.00B25.57%
-0.00B14.19%
+0.00B11.38%
EPSExceed expectations
-0.9682.55%
-1.106779.88%
+0.14672.67%
Upcoming earnings report - FY2026 Q2 Earning Release
Available dateAug 11, 2026
Estimate Revenue0
Estimate EBIT-2.733 M
Estimate EPS-0.97
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf